openPR Logo
Press release

Somavert Market Is Likely to Experience a Tremendous Growth by 2029

11-29-2023 02:06 PM CET | Health & Medicine

Press release from: Orion Market Research

Somavert Market Is Likely to Experience a Tremendous Growth

Somavert Market is estimated to grow at a significant CAGR during the forecast period. Somavert is a human-made protein, similar to the growth hormone of humans. Pegvisomant binds to the body receptor and blocks the effects of the growth hormone. Somavert is typically given without successful symptom treatment after other medications, surgery or radiation have been treated. Somavert is an enzyme or drug that is used to treat the hormone acromegaly that causes excessive growth hormone (EGH) in adults. In body areas such as the hands, feet and face, patients with this disease have large bones. Acromegaly is the result of non-cancerous growth and affects mostly mid-aged adults. The enzyme can inhibit GH expansion as a growth hormone receptor antagonist and return blood insulin growth factor I (IGF-I) levels in patients with acromegaly to normal.

Global awareness of hormone problem drugs and therapies is increasing is the driving factor that is driving the market expansion. The improved overall clinical status of the patient as a result of treatment has contributed significantly to the growth of the market. The rise in the number of patients, particularly among adults, with this rare disease increases the demand for this drug that is expected to significantly boost the market growth. Technological advances and increased R&D expenses in the discovery of innovative products by major manufacturers offer advanced opportunities that boost the market growth.

Somavert (pegvisomant) is a sterile, white lyophilized injector for reconstitution in subcutaneous form. The Somavert packages are supplied with a separate glass vial that includes sterile injection water, USP, a sterile non-pyrogenic water preparation for injection that does not contain a diluent bacteriostatic, antimicrobial agent, and buffer. Somavert (Pegvisomant for injecting) has been approved by the FDA to treat acromegaly in patients who have had or are not appropriate for inadequate response with surgery and radiation therapy and other medical treatments.

 To Request a Sample of our Report on Somavert Market:  https://www.omrglobal.com/request-sample/somavert-market

Market Coverage

The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030

Segments Covered

By Type
By Application

Regions Covered

North America
Europe
Asia-Pacific
Rest of the world
Competitive Landscape- Chiasma, Inc., F.Hoffmann La Roche, Ltd., Boehringer Ingelheim International GmbH, Novartis AG, and Ipsen Group., among others.  

A full Report of Somavert Market is Available at:  https://www.omrglobal.com/industry-reports/somavert-market

Somavert Drug Market by Segments

By Type

Prefilled
Non-Prefilled

By application

Hospital
Pharmacy

Somavert Drug Market by Regions

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan 
South Korea
Rest of APAC

Rest of The World

Latin America 
Middle East & Africa

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/somavert-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Somavert Market Is Likely to Experience a Tremendous Growth by 2029 here

News-ID: 3309030 • Views:

More Releases from Orion Market Research

Polyetherimide (PEI) Market Outlook 2024-2031: Trends and Opportunities/ 3M Co., DowDuPont, Inc., Ensinger Plastics Pvt. Ltd.
Polyetherimide (PEI) Market Outlook 2024-2031: Trends and Opportunities/ 3M Co., …
The global polyetherimide (PEI) market is projected to showcase steady growth during the forecast period. The rapid increase in a wide range of applications is one of the major factors to drive the growth of the PEI market across the globe. PEI is an amorphous thermoplastic having high strength and rigidity at elevated temperatures, long term heat resistance, dimensional stability, and good electrical properties. The PEI resins are both chemical
Potassium Sulphate MarketSize, Share, Trends, Demand, Segments, Leading Companies and Forecast till 2031 / China Ching Shiang Chemical Co. Ltd., K+S AG, SOPerior Fertilizer Corp., Qing Shang Chemical
Potassium Sulphate MarketSize, Share, Trends, Demand, Segments, Leading Companie …
Potassium Sulphate Market is anticipated to grow at a considerable CAGR of 9.2% during the forecast period. The advancement of the potassium sulphate production process is significantly supporting the growth of the market. For instance, a research paper was published on ResearchGate GmbH, according to which potassium sulphate can be prepared from phosphogypsum in the system of ethanol and ammonia. The optimum conditions were obtained through the reaction of 6%
Packaged Salad Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031/ BONDUELLE, Summer Fresh Salads Inc., Gotham Greens
Packaged Salad Market Size, Trends, Latest Insights, Analysis and Forecast 2024- …
The global packaged salad market is anticipated to grow at a considerable CAGR of 7.0% during the forecast period. The rising need and demand for packaged food are one of the prime factors affecting and driving the market. Packaged food supports in decreasing the damage and food spoilage along with keeping it with vital nutrients. Additionally, it removes the risk associated with tampering and adulteration which in turn provides ease
Jewellery Market Is Expected to Exhibit Significant Growth Over 2031 / Cartier International SNC, Louis Vuitton Malletier (Louis Vuitton), Compagnie Financière Richemont S.A. (Richemont)
Jewellery Market Is Expected to Exhibit Significant Growth Over 2031 / Cartier I …
The global jewellery market is anticipated to grow at a considerable CAGR of 4.6% during the forecast period (2024-2031). The growth of the jewellery market can be attributed to several factors, including changing lifestyles of the population across the globe along with the rising prices of precious metals such as gold, silver, and others. that has led to a shift in consumer preferences heightened jewellery toward alternative materials such

All 5 Releases


More Releases for Somavert

COVID-19 Antigen Testing Kits Market by Trends, Dynamic Innovation in Technology …
This unique COVID-19 Antigen Testing Kits market research study also presents important data about COVID-19 and its effects on different industries. It further explains how industries are trying to come out of this pandemic condition to set their business in the market again. It also concentrates on some of the important sources to use while doing business for accomplishing huge profits. Such great exploration market analysis further emphasizes on
Acromegaly Treatment Market Report Up to 2031
Visiongain has published a new report on Acromegaly Treatment Market Report to 2031: Forecasts By Disease Type (Ectopic Acromegaly and Pseudo Acromegaly), By Drug Class (Somatostatin Analogs (SSAs) (Somatuline Depot and Other SSAs), Dopamine Agonists (Bromocriptine Mesylate and Other Dopamine Agonists), and Growth Hormone Receptor Antagonist (Somavert)), By Route of Administration (Oral and Parenteral), and By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online pharmacies) PLUS COVID-19 Recovery Scenarios. COVID-19 Impact
Somavert Drugs Market In-deep Analysis And Experts Review Report 2020-2025
The report titled “Somavert Drugs Market” has recently added by MarketInsightsReports to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners, and industry experts. The Somavert Drugs was valued at 49500
Global Somavert Industry 2020 Market Research With Size, Growth, Manufacturers, …
" DataIntelo, a prominent market research firm, has published a detailed report on Global Somavert Market. This market research report provides comprehensive and in-depth analysis on the market which can possibly help an enterprise to identify lucrative opportunities and assist them with fabricating creative business strategies. The market report provides information about the current market scenario regarding the global supply and demand, key market trends and opportunities in the market, and
Somavert Market 2019: Worldwide Industry Production, Sales, Share, Future Trends …
The global Somavert Market 2019 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. This report presents the worldwide Somavert Market size (value, production and consumption), splits the breakdown (data status 2014-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market
2025 Projections: Global Somavert Drugs Market Latest Achievements and Opportuni …
Qyresearchreports include new market research report Global Somavert Drugs Market Insights, Forecast to 2025 to its huge collection of research reports. Pegvisomant(trade nameSomavert) is agrowth hormone receptorantagonistused in the treatment ofacromegaly. In 2017, the global Somavert Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project